IBA SA : IBA and Elekta enter an MOU regarding a comprehensive partnership including joint software development and sales to ...
September 23 2017 - 10:00AM
IBA and Elekta
enter an MOU regarding a comprehensive partnership including joint
software development and sales to advance proton therapy
treatments
SAN DIEGO,
September 23, 2017 - IBA (Ion Beam Applications) and Elekta
(EKTA-B.ST) announced today that they have entered a Memorandum of
Understanding (MOU) to agree to work closely together in software
development as well as the sales and marketing of each other's
products. The announcement was made at the occasion of the American
Society for Radiation Oncology (ASTRO) Annual Meeting, which is
taking place September 24-27 in San Diego.
The companies intend to co-invest
in developing new functionality for proton therapy treatment in
Elekta's Monaco® treatment
planning system and MOSAIQ® oncology
information system. The purpose is to offer a more seamless
experience for comprehensive radiotherapy departments and further
improve patient care.
In addition to the software
development collaboration, both companies expect to offer a joint
portfolio of radiation therapy solutions and co-market each other's
products, based on a shared vision of integration and adaptive
radiation therapy.
Richard Hausmann,
President and CEO of Elekta, says: "We believe that proton
therapy is an important tool in radiation treatment for specific
indications and we are very pleased to partner with IBA, the global
leader in proton therapy, to further integrate their products into
our software solutions."
Olivier Legrain,
IBA CEO, adds: "Elekta has always been a pioneer in the field
of radiation therapy. Our culture of innovation and collaboration
fits well with Elekta and we are excited to join forces based on a
shared vision of integration."
***ENDS***
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology
company focused on bringing integrated and innovative solutions for
the diagnosis and treatment of cancer. The company is the worldwide
technology leader in the field of proton therapy, considered to be
the most advanced form of radiation therapy available today. IBA's
proton therapy solutions are flexible and adaptable, allowing
customers to choose from universal full-scale proton therapy
centers as well as compact, single room solutions. In addition, IBA
also has a radiation dosimetry business and develops particle
accelerators for the medical world and industry. Headquartered in
Belgium and employing about 1,500 people worldwide, IBA has
installed systems across the world.
IBA is listed on the pan-European
stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg
IBAB.BB).
More information can be found at: www.iba-worldwide.com
About Elekta
Elekta is proud to be the leading innovator of
equipment and software used to improve, prolong and save the lives
of people with cancer and brain disorders. Our advanced, effective
solutions are created in collaboration with customers, and more
than 6,000 hospitals worldwide rely on Elekta technology. Our
treatment solutions and oncology informatics portfolios are
designed to enhance the delivery of radiation therapy, radiosurgery
and brachytherapy, and to drive cost efficiency in clinical
workflows. Elekta employs 3,600 people around the world.
Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ
Stockholm. www.elekta.com
For further information, please
contact:
Elekta
Gert van Santen, Group Vice
President Corporate Communications, Elekta AB
Tel: +31 653 561 242, e-mail: gert.vansanten@elekta.com
Time zone: CET: Central European Time
Tobias Bülow, Director Financial Communications, Elekta
AB
Tel: +46 722 215 017, e-mail:
tobias.bulow@elekta.com
Time zone: CET: Central European Time
IBA
Bernard Dandoy; Investor
Relations
Soumya Chandramouli; Chief Financial
Officer
Thomas Ralet; Vice-President Corporate Communication
+32 10 475 890
Investorrelations@iba-group.com
Consilium
Strategic Communications
Amber Fennell, Matthew Neal, Ivar
Milligan
+44 (0) 20 3709 5700
IBA@consilium-comms.com
Elekta_IBA_170923_EN
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: IBA SA via Globenewswire
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ion Beam Applications (EU:IBAB)
Historical Stock Chart
From Apr 2023 to Apr 2024